How to Properly Diagnose and Treat Immune-Related Adverse Events During Immunotherapy in Patients with Cancer: Discussion Between Specialists

Cancers 2026 Open access

Read full text
Authors: Angioletta Lasagna, Paolo Sacchi
DOI: 10.3390/cancers18030523
Cited by: 0
References: 7

Abstract

Immune checkpoint inhibitors and other immune-based cancer therapies have profoundly transformed the treatment of solid and hematological malignancies, leading to durable responses and significant survival benefits in a growing number of patients [...].

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Pharmacovigilance and Adverse Drug Reactions Immunotherapy and Immune Responses

Publication details

Journal / source
Cancers
Volume
18
Issue
3
Pages
523–523
Publication date
5 February 2026
Language
EN